Roles for DevelopmentallyRegulated microRNAs in Neonatal Immunity
发育调控的 microRNA 在新生儿免疫中的作用
基本信息
- 批准号:10221489
- 负责人:
- 金额:$ 40.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-18 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAntigensApoptosisBacille Calmette-Guerin vaccinationBacteriaBehaviorCD8-Positive T-LymphocytesCell Differentiation processCell physiologyCellsDataDevelopmentEffector CellEquilibriumExperimental ModelsGene TargetingGenerationsGenesGoalsGrantHumanImmune responseImmunityImmunologicsImpairmentIn VitroInfectionInflammationLaboratoriesLeadLifeLinkMalawiMemoryMessenger RNAMicroRNAsModelingMolecularMusNeonatalNewborn InfantPatternPlayPositioning AttributeProliferatingPublishingRegulator GenesRoleSchoolsT cell regulationT cell responseT memory cellT-Cell ActivationT-Cell ProliferationT-LymphocyteTestingTranslatingTropical MedicineUniversitiesUp-RegulationVaccinationVaccinesVirusWorkage relatedagedbasecell behaviordifferential expressionimprovedin vivoinnovationinsightinterestneonatal immunityneonatenext generation sequencingnovel therapeutic interventionpathogenpredictive markerresponseskillstranscription factorvaccine efficacy
项目摘要
Project Summary /Abstract
Neonates are highly susceptible to infection and respond poorly to vaccination for reasons that are not well
understood. Based on our published data, we believe that neonates are particularly vulnerable to repeat
infections because their naïve CD8+ T cells are intrinsically defective at differentiating into memory CD8+ T cells.
A major goal of this grant is to identify the key gene regulatory networks that underlie cell-intrinsic differences
between neonatal and adult CD8+ T cells. Since microRNAs (miRNAs) are developmentally regulated and
required for CD8+ T cell function, we hypothesized that defective CD8+ T cell memory formation in early life may
be due to differences in miRNA expression patterns between neonatal and adult CD8+ T cells. To test our
hypothesis, we used next generation sequencing to identify mouse miRNAs that are differentially regulated in
neonatal and adult CD8+ T cells throughout the response to infection. Surprisingly, our results indicated that
differences in miRNA expression profiles were most pronounced prior to immunological challenge, suggesting
that developmentally-regulated miRNAs do not operate by altering the fate of effector cells at the peak of the
response. Instead, these miRNAs appear to set the activation threshold prior to infection, causing neonatal
CD8+ T cells to differentiate more rapidly into effector cells and biasing them away from a memory precursor
fate. We are particularly interested in two miRNAs (miR-29 and miR-130), which we believe play a major role in
cell-intrinsic differences that exist between neonatal and adult CD8+ T cells in mice and humans. MiR-130 is
preferentially expressed in neonatal CD8+ T cells and targets a number of genes involved in negative regulation
of T cell proliferation or apoptosis. MiR-29, on the other hand, is more abundant in adult CD8+ T cells and
regulates the expression of transcription factors involved in effector and memory cell differentiation. We propose
that the miR-29/miR-130 axis acts as a developmental rheostat for adjusting the activation threshold of CD8+ T
cells, controlling the balance between rapid effector cells (neonates) and long-lived memory cells (adults). The
main objectives of this proposal are to determine how age-related changes in miR-29 and miR-130 expression
alter the ability of CD8+ T cells to respond to infection (Aim 1); identify the key target genes regulated by miR-
29 and miR-130 prior to activation (Aim 2); and determine whether miR-29 and miR-130 can predict vaccine-
specific CD8+ T cell responses in newborns (Aim 3). Accomplishing these aims will lend support for a new
model describing how miRNAs regulate the CD8+ T cell response to infection, which can lead to novel
therapeutic strategies for enhancing the development of memory CD8+ T cells in early life.
项目总结/摘要
新生儿对感染高度敏感,对疫苗接种反应不佳,原因是
明白根据我们发表的数据,我们认为新生儿特别容易重复
感染,因为他们的幼稚CD 8 + T细胞在分化为记忆CD 8 + T细胞方面存在固有缺陷。
这项资助的一个主要目标是确定细胞内在差异背后的关键基因调控网络
新生儿和成人CD 8 + T细胞之间的差异。由于microRNAs(miRNAs)是发育调控的,
由于CD 8 + T细胞的功能是必需的,因此我们假设,早期生命中CD 8 + T细胞记忆形成缺陷可能
这可能是由于新生儿和成人CD 8 + T细胞之间miRNA表达模式的差异。来测试我们
假设,我们使用下一代测序来鉴定小鼠miRNAs,这些miRNAs在以下方面受到差异调节:
新生儿和成人的CD 8 + T细胞在整个感染反应。令人惊讶的是,我们的结果表明,
在免疫攻击前,miRNA表达谱的差异最明显,表明
发育调控的miRNAs并不通过改变效应细胞在发育高峰期的命运来发挥作用,
反应相反,这些miRNAs似乎在感染前设定了激活阈值,导致新生儿
CD 8 + T细胞更快地分化为效应细胞,并使它们远离记忆前体
命运我们特别感兴趣的是两种miRNAs(miR-29和miR-130),我们认为它们在
在小鼠和人类中,新生儿和成人CD 8 + T细胞之间存在细胞内在差异。MiR-130是
优先在新生儿CD 8 + T细胞中表达,并靶向参与负调控的许多基因
T细胞增殖或凋亡。另一方面,miR-29在成人CD 8 + T细胞中更丰富,
调节参与效应细胞和记忆细胞分化的转录因子的表达。我们提出
miR-29/miR-130轴作为发育变阻器调节CD 8 + T细胞活化阈值,
细胞,控制快速效应细胞(新生儿)和长寿记忆细胞(成人)之间的平衡。的
本研究的主要目的是确定miR-29和miR-130表达的年龄相关变化
改变CD 8 + T细胞对感染应答的能力(Aim 1);确定由miR-1调控的关键靶基因;
29和miR-130之间的差异(目的2);并确定miR-29和miR-130是否可以预测疫苗的免疫应答。
新生儿中特异性CD 8 + T细胞应答(目的3)。实现这些目标将有助于建立一个新的
描述了miRNAs如何调节CD 8 + T细胞对感染的反应的模型,这可以导致新的
增强生命早期记忆性CD 8 + T细胞发育的治疗策略。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW W GRIMSON其他文献
ANDREW W GRIMSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW W GRIMSON', 18)}}的其他基金
MicroRNAs in Tissue-resident memory T cells
组织驻留记忆 T 细胞中的 MicroRNA
- 批准号:
10609026 - 财政年份:2022
- 资助金额:
$ 40.02万 - 项目类别:
MicroRNAs in Tissue-resident memory T cells
组织驻留记忆 T 细胞中的 MicroRNA
- 批准号:
10354926 - 财政年份:2022
- 资助金额:
$ 40.02万 - 项目类别:
Impact of 3' untranslated region sequence variants in spermiogenic gene expression and infertility
3非翻译区序列变异对精子发生基因表达和不育的影响
- 批准号:
10157201 - 财政年份:2021
- 资助金额:
$ 40.02万 - 项目类别:
Impact of 3' untranslated region sequence variants in spermiogenic gene expression and infertility
3非翻译区序列变异对精子发生基因表达和不育的影响
- 批准号:
10398877 - 财政年份:2021
- 资助金额:
$ 40.02万 - 项目类别:
Impact of 3' untranslated region sequence variants in spermiogenic gene expression and infertility
3非翻译区序列变异对精子发生基因表达和不育的影响
- 批准号:
10615700 - 财政年份:2021
- 资助金额:
$ 40.02万 - 项目类别:
A Single Comprehensive Assay for Gene Regulatory Profiling Optimized for Minimal Sample Input Requirements
针对最小样本输入要求进行优化的基因调控分析的单一综合分析
- 批准号:
10398158 - 财政年份:2020
- 资助金额:
$ 40.02万 - 项目类别:
A Single Comprehensive Assay for Gene Regulatory Profiling Optimized for Minimal Sample Input Requirements
针对最小样本输入要求进行优化的基因调控分析的单一综合分析
- 批准号:
10159213 - 财政年份:2020
- 资助金额:
$ 40.02万 - 项目类别:
Establishing Methods to Delineate 3'UTR-mediated Regulation
建立描述 3UTR 介导调节的方法
- 批准号:
10316261 - 财政年份:2020
- 资助金额:
$ 40.02万 - 项目类别:
A Single Comprehensive Assay for Gene Regulatory Profiling Optimized for Minimal Sample Input Requirements
针对最小样本输入要求进行优化的基因调控分析的单一综合分析
- 批准号:
10618150 - 财政年份:2020
- 资助金额:
$ 40.02万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 40.02万 - 项目类别:
Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 40.02万 - 项目类别:
Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 40.02万 - 项目类别:
Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 40.02万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 40.02万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 40.02万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 40.02万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 40.02万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 40.02万 - 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 40.02万 - 项目类别:














{{item.name}}会员




